‘Remarkable’ Survival Outcomes in Cisplatin-Ineligible Bladder Cancer

By News Health
6 hours Ago

(MedPage Today) — BERLIN — Patients with cisplatin-ineligible bladder cancer had huge reductions in clinical events and cancer death when treated with a novel combination therapy before and after surgery, according to a randomized trial reported…

Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118024

Author :

Publish date : 2025-10-19 21:33:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Multiple Viral Infections Alter Stem Cell Transplant Success

Where Have All the Obstetricians Gone?

Trastuzumab Deruxtecan Scores Two Wins in HER2-Positive Early Breast Cancer

'It Could Be Cheap, but It Still Could Be Poison': What We Heard This Week

OS Win for Enzalutamide in Prostate Cancer at High Risk for Biochemical Recurrence

Could Thymic Health Predict Immunotherapy Outcomes?